合成生物学技术研究进展

doi:10.13560/j.cnki.biotech.bull.1985.2015.03.017

摘要/Abstract

摘要： 合成生物学是一门将生物学工程化的应用学科，目的在于将生命元件标准化和模块化；也可用于生命起源等基础理论研究。对合成生物学进行了较为详细地介绍，主要综述了合成生物学领域新出现的方法及应用。

关键词: 合成生物学, 生物功能元件, 无细胞合成生物学, 最小基因组, 定向进化, 基因组编辑

Abstract: Synthetic biology is an applied discipline that introduces engineering into biology. The aim of synthetic biology is to standardize and modularize biological parts. It can also be applied in the basic researches，such as the research of life origin. This review gives a detailed introduction to the synthetic biology，especially the new methods and applications.

Key words: synthetic biology, biological part, cell-free synthetic biology, minimal genome, directed evolution, genome editing

吕永坤,堵国成,陈坚,周景文. 合成生物学技术研究进展[J]. 生物技术通报, 2015, 31(4): 134-148.

Lü Yongkun, Du Guocheng, Chen Jian, Zhou Jingwen. Advances in Synthetic Biology[J]. Biotechnology Bulletin, 2015, 31(4): 134-148.

参考文献

[1] Zhang L, Chang S, Wang J. Synthetic biology：From the first synthetic
cell to see its current situation and future development［J］. Chinese Science Bulletin, 2011, 56（3）：229-237.
[2] Mitchell W. Natural products from synthetic biology［J］. Current Opinion in Chemical Biology, 2011, 15（4）：505-515.
[3] Gibson DG, Glass JI, Lartigue C, et al. Creation of a bacterial cell controlled by a chemically synthesized genome［J］. Science, 2010, 329（5987）：52-56.
[4] Bailey JE. Toward a science of metabolic engineering［J］. Science, 1991, 252（5013）：1668-1675.
[5] Stephanopoulos G, Vallino JJ. Network rigidity and metabolic engineering in metabolite overproduction［J］. Science, 1991, 252（5013）：1675-1681.
[6] Xie LZ, Wang DIC. High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor［J］. Biotechnology and Bioengineering, 1996, 51（6）：725-729.
[7] Hamilton SR, Bobrowicz P, Bobrowicz B, et al. Production of complex human glycoproteins in yeast［J］. Science, 2003, 301（5637）：1244-1246.
[8] Stephanopoulos G. Challenges in engineering microbes for biofuels production［J］. Science, 2007, 315（5813）：801-804.
[9] Kitney R, Freemont P. Synthetic biology-the state of play［J］. Febs Letters, 2012, 586（15）：2029-2036.
[10] Elowitz MB, Leibler S. A synthetic oscillatory network of transcriptional regulators［J］. Nature, 2002, 403（6767）：335-338.
[11] Gardner TS, Cantor CR, Collins JJ. Construction of a genetic toggle switch in Escherichia coli［J］. Nature, 2000, 403（6767）：339-342.
[12] Smith HO, Hutchison CA, Pfannkoch C, Venter JC. Generating a synthetic genome by whole genome assembly：phi X174 bacteriophage from synthetic oligonucleotides［J］. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100（26）：15440-15445.
[13] Good MC, Zalatan JG, Lim WA. Scaffold proteins：Hubs for controlling the flow of cellular information［J］. Science, 2011, 332（6030）：680-686.
[14] Weber W, Fussenegger M. The impact of synthetic biology on drug discovery［J］. Drug Discovery Today, 2009, 14（19-20）：956-963.
[15] Rebatchouk D, Daraselia N, Narita JO. NOMAD：A versatile strategy for in vitro DNA manipulation applied to promoter analysis and vector design［J］. Proceedings of the National Academy of Sciences of the United States of America, 1996, 93（20）：10891-10896.
[16] Kwok R. Five hard truths for synthetic biology［J］. Nature, 2010, 463（7279）：288-290.
[17] Hodgman CE, Jewett MC. Cell-free synthetic biology：Thinking outside the cell［J］. Metabolic Engineering, 2012, 14（3）：261-269.
[18] Smith MT, Wilding KM, Hunt JM, et al. The emerging age of cell-free synthetic biology［J］. Febs Letters, 2014, 588（17）：2755-2761.
[19] Swartz JR. Transforming biochemical engineering with cell-free biology［J］. Aiche Journal, 2012, 58（1）：5-13.
[20] Harris DC, Jewett MC. Cell-free biology：Exploiting the interface between synthetic biology and synthetic chemistry［J］. Current Opinion in Biotechnology, 2012, 23（5）：672-678.
[21] Forster AC, Church GM. Synthetic biology projects in vitro［J］. Genome Research, 2007, 17（1）：1-6.
[22] Lopez-Gallego F, Schmidt-Dannert C. Multi-enzymatic synthesis［J］. Current Opinion in Chemical Biology, 2010, 14（2）：174-183.
[23] Zawada JF, Yin G, Steiner AR, et al. Microscale to manufacturing scale-up of cell-free cytokine production-A new approach for shortening protein production development timelines［J］. Biotechnology and Bioengineering, 2011, 108（7）：1570-1578.
[24] Kanter G, Yang J, Voloshin A, et al. Cell-free production of scFv fusion proteins：an efficient approach for personalized lymphoma vaccines［J］. Blood, 2007, 109（8）：3393-3399.
[25] Bundy BC, Franciszkowicz MJ, Swartz JR. Escherichia coli-based cell-free synthesis of virus-like particles［J］. Biotechnology and Bioengineering, 2008, 100（1）：28-37.
[26] Boyer ME, Stapleton JA, Kuchenreuther JM, et al. Cell-free synthesis and maturation of［FeFe］hydrogenases［J］. Biotechnology and Bioengineering, 2008, 99（1）：59-67.
[27] Bujara M, Schuemperli M, Billerbeek S, et al. Exploiting cell-free systems：Implementation and debugging of a system of biotransformations［J］. Biotechnology and Bioengineering, 2010, 106（3）：376-389.
[28] Zhang YHP. Production of biocommodities and bioelectricity by cell-free synthetic enzymatic pathway biotransformations：Challenges and opportunities［J］. Biotechnology and Bioengineering, 2010, 105（4）：663-677.
[29] Wang Y, Huang W, Sathitsuksanoh N, et al. Biohydrogenation from biomass sugar mediated by in vitro synthetic enzymatic pathways［J］. Chemistry & Biology, 2011, 18（3）：372-380.
[30] Sun ZZ, Yeung E, Hayes CA, et al. Linear DNA for rapid prototyping of synthetic biological circuits in an Escherichia coli based TX-TL cell-free system［J］. Acs Synthetic Biology, 2014, 3（6）：387-397.
[31] Singh-Blom A, Hughes RA, Ellington AR. Residue-specific incorpora-tion of unnatural amino acids into proteins in vitro and in vivo［M/OL］//Samuelson JC. Enzyme Engineering, Methods in Molecular Biology. Humana Press, 2013, 978: 93-114.
[32] Liu CC, Schultz PG. Adding new chemistries to the genetic code［J］. Annual Review of Biochemistry, 2010, 79（1）：413-444.
[33] Zimmerman ES, Heibeck TH, Gill A, et al. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system［J］. Bioconjugate Chemistry, 2014, 25（2）：351-361.
[34] Smith MT, Wu JC, Varner CT, Bundy BC. Enhanced protein stability through minimally invasive, direct, covalent, and site-specific immobilization［J］. Biotechnology Progress, 2013, 29（1）：247-254.
[35] Smith MT, Hawes AK, Bundy BC. Reengineering viruses and virus-like particles through chemical functionalization strategies［J］. Current Opinion in Biotechnology, 2013, 24（4）：620-626.
[36] Loscha KV, Herlt AJ, Qi R, et al. Multiple-site labeling of proteins
with unnatural amino acids［J］. Angewandte Chemie-Internatio-nal Edition, 2013, 51（9）：2243-2246.
[37] Yang Z, Hutter D, Sheng P, et al. Artificially expanded genetic information system：a new base pair with an alternative hydrogen bonding pattern［J］. Nucleic Acids Research, 2006, 34（21）：6095-6101.
[38] Yang Z, Chen F, Alvarado JB, Benner SA. Amplification, mutation, and sequencing of a six-letter synthetic genetic system［J］. Journal of the American Chemical Society, 2011, 133（38）：15105-15112.
[39] Acevedo-Rocha CG, Fang G, Schmidt M, et al. From essential to persistent genes：a functional approach to constructing synthetic life［J］. Trends in Genetics, 2013, 29（5）：273-279.
[40] Juhas M, Eberl L, Glass JI. Essence of life：essential genes of minimal genomes［J］. Trends in Cell Biology, 2011, 21（10）：562-568.
[41] Lagesen K, Ussery DW, Wassenaar TM. Genome update：the 1000th genome - a cautionary tale［J］. Microbiology-Sgm, 2010, 156：603-608.
[42] McCutcheon JP. The bacterial essence of tiny symbiont genomes
［J］. Current Opinion in Microbiology, 2010, 13（1）：73-78.
[43] Liu MF, Cescau S, Mechold U, et al. Identification of a novel nanoRNase in Bartonella［J］. Microbiology-Sgm, 2012, 158：886-895.
[44] Ouzounis CA, Kunin V, Darzentas N, Goldovsky L. A minimal estimate for the gene content of the last universal common ancestor - exobiology from a terrestrial perspective［J］. Research in Microbiology, 2006, 157（1）：57-68.
[45] Kim KM, Caetano-Anolles G. The evolutionary history of protein fold families and proteomes confirms that the archaeal ancestor is more ancient than the ancestors of other superkingdoms［J］. Bmc Evolutionary Biology, 2012, 12：13.
[46] Lukjancenko O, Wassenaar TM, Ussery DW. Comparison of 61 sequenced Escherichia coli genomes［J］. Microbial Ecology, 2010, 60（4）：708-720.
[47] Anthony JR, Anthony LC, Nowroozi F, et al. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4, 11-diene［J］. Metabolic Engineering, 2009, 11（1）：13-19.
[48] Yadav VG, De Mey M, Lim CG, et al. The future of metabolic engineering and synthetic biology：Towards a systematic practice［J］. Metabolic Engineering, 2012, 14（3）：233-241.
[49] Perez-Pinera P, Ousterout DG, Gersbach CA. Advances in targeted genome editing［J］. Current Opinion in Chemical Biology, 2012, 16（3-4）：268-277.
[50] Kim S, Lee MJ, Kim H, et al. Preassembled zinc-finger arrays for rapid construction of ZFNs［J］. Nature Methods, 2011, 8（1）：7.
[51] Bhakta MS, Henry IM, Ousterout DG, et al. Highly active zinc-finger nucleases by extended modular assembly［J］. Genome Research, 2013, 23（3）：530-538.
[52] Miller JC, Tan S, Qiao G, et al. A TALE nuclease architecture for efficient genome editing［J］. Nature Biotechnology, 2011, 29（2）：143-148.
[53] Gaj T, Gersbach CA, Barbas CF III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering［J］. Trends in Biotechnology, 2013, 31（7）：397-405.
[54] Bhaya D, Davison M, Barrangou R. CRISPR-Cas systems in bacteria and archaea：versatile small RNAs for adaptive defense and regulation［J］. Annual Review of Genetics, 2011, 45：273-297.
[55] Gasiunas G, Siksnys V. RNA-dependent DNA endonuclease Cas9 of the CRISPR system：Holy Grail of genome editing?［J］. Trends in Microbiology, 2013, 21（11）：562-567.
[56] Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity［J］. Science, 2012, 337（6096）：816-821.
[57] Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system［J］. Nature Protocols, 2013, 8（11）：2281-2308.
[58] Jiang W, Bikard D, Cox D, et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems［J］. Nature Biotechnology, 2013, 31（3）：233-239.
[59] Yu Z, Ren M, Wang Z, et al. Highly Efficient genome modifications mediated by CRISPR/Cas9 in Drosophila［J］. Genetics, 2013, 195（1）：289-291.
[60] Gilbert LA, Larson MH, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes［J］. Cell, 2013, 154（2）：442-451.
[61] Cobb RE, Sun N, Zhao H. Directed evolution as a powerful synthetic biology tool［J］. Methods, 2013, 60（1）：81-90.
[62] Cobb RE, Si T, Zhao H. Directed evolution：an evolving and enabling synthetic biology tool［J］. Current Opinion in Chemical Biology, 2012, 16（3-4）：285-291.
[63] Zha W, Rubin-Pitel SB, Zhao H. Exploiting genetic diversity by directed evolution：molecular breeding of type III polyketide synthases improves productivity［J］. Molecular BioSystems, 2008, 4（3）：246-248.
[64] Atsumi S, Liao JC. Directed evolution of Methanococcus jannaschii citramalate synthase for biosynthesis of 1-propanol and 1-butanol by Escherichia coli［J］. Applied and Environmental Microbiology, 2008, 74（24）：7802-7808.
[65] Filipovska A, Rackham O. Building a parallel metabolism within the cell［J］. Acs Chemical Biology, 2008, 3（1）：51-63.
[66] Liu CC, Mack AV, Brustad EM, et al. Evolution of proteins with genetically encoded “Chemical warheads”［J］. Journal of the American Chemical Society, 2009, 131（28）：9616-9617.
[67] Pfleger BF, Pitera DJ, Smolke CD, Keasling JD. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes［J］. Nat Biotech, 2006, 24（8）：1027-1032.
[68] Chen F, Gaucher EA, Leal NA, et al. Reconstructed evolutionary adaptive paths give polymerases accepting reversible terminators for sequencing and SNP detection［J］. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107（5）：1948-1953.
[69] Wang Q, Wu H, Wang A, et al. Prospecting metagenomic enzyme subfamily genes for DNA family shuffling by a novel PCR-based approach［J］. Journal of Biological Chemistry, 2010, 285（53）：41509-41516.
[70] Dickinson BC, Packer MS, Badran AH, Liu DR. A system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutations［J］. Nat Commun, 2014, 5：5352.
[71] Luan G, Cai Z, Li Y, Ma Y. Genome replication engineering assisted continuous evolution（GREACE）to improve microbial tolerance for biofuels production［J］. Biotechnology for Biofuels, 2013, 6（1）：137.
[72] Connor MR, Atsumi S. Synthetic biology guides biofuel production［J］. Journal of Biomedicine and Biotechnology, 2010, doi：10. 1155/2010/541698.
[73] Wang B, Wang J, Zhang W, Meldrum DR. Application of synthetic biology in cyanobacteria and algae［J］. Frontiers in Microbiology, 2012, 3：344.
[74] Jin H, Chen L, Wang J, Zhang W. Engineering biofuel tolerance in non-native producing microorganisms［J］. Biotechnology Advances, 2014, 32（2）：541-548.
[75] Ramos JL, Duque E, Gallegos MT, et al. Mechanisms of solvent tolerance in gram-negative bacteria［J］. Annual Review of Microbiology, 2002, 56：743-768.
[76] Lo TM, Teo WS, Ling H, et al. Microbial engineering strategies to improve cell viability for biochemical production［J］. Biotechnology Advances, 2013, 31（6）：903-914.
[77] Shao X, Raman B, Zhu M, et al. Mutant selection and phenotypic and genetic characterization of ethanol-tolerant strains of Clostridium thermocellum［J］. Applied Microbiology and Biotechnology, 2011, 92（3）：641-652.
[78] Kim HJ, Turner TL, Jin YS. Combinatorial genetic perturbation to refine metabolic circuits for producing biofuels and biochemicals
［J］. Biotechnology Advances, 2013, 31（6）：976-985.
[79] Lee SJ, Lee SJ, Lee DW. Design and development of synthetic microbial platform cells for bioenergy［J］. Frontiers in Microbiology, 2013, 4：92.
[80] Martin VJJ, Pitera DJ, Withers ST, et al. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids［J］. Nature Biotechnology, 2013, 21（7）：796-802.
[81] Ro DK, Paradise EM, Ouellet M, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast［J］. Nature, 2006, 440（7086）：940-943.
[82] Zhu S, Wu J, Du G, et al. Efficient synthesis of eriodictyol from L-tyrosine in Escherichia coli［J］. Applied and Environmental Microbiology, 2014, 80（10）：3072-3080.
[83] Neumann H, Neumann-Staubitz P. Synthetic biology approaches in drug discovery and pharmaceutical biotechnology［J］. Applied Microbiology and Biotechnology, 2010, 87（1）：75-86.
[84] Nguyen VH, Kim HS, Ha JM, et al. Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer［J］. Cancer Research, 2010, 70（1）：18-23.
[85] Neumann H, Hancock SM, Buning R, et al. A Method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation［J］. Molecular Cell, 2009, 36（1）：153-163.
[86] Caschera F, Noireaux V. Integration of biological parts toward the synthesis of a minimal cell［J］. Current Opinion in Chemical Biology, 2014, 22：85-91.
[87] Noireaux V, Maeda YT, Libchaber A. Development of an artificial cell, from self-organization to computation and self-reproduction［J］. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108（9）：3473-3480.